Valuation: Codexis, Inc.

Market Cap 162M 140M 133M 120M 226M 15.53B 227M 1.58B 610M 7.88B 609M 595M 25.05B P/E 2026 *
-3.98x
P/E 2027 * -5.17x
Enterprise Value 162M 140M 133M 120M 226M 15.53B 227M 1.58B 610M 7.88B 609M 595M 25.05B EV / Sales 2026 *
2.19x
EV / Sales 2027 * 1.83x
Free-Float
92.88%
Yield 2026 *
-
Yield 2027 * -
1 day+1.02%
1 week+1.37%
Current month-12.94%
1 month-5.13%
3 months-38.33%
6 months-8.07%
Current year-9.20%
1 week 1.4
Extreme 1.405
1.5
1 month 1.4
Extreme 1.405
1.76
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 2025-11-06
Director of Finance/CFO 59 2024-09-29
Chief Tech/Sci/R&D Officer 56 2020-05-04
Director TitleAgeSince
Director/Board Member 66 2016-02-29
Director/Board Member 59 2025-11-06
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
2/23/26 Free

Chief Financial Officer

316,100 0.3500%
2/23/26 Sell

Chief Technology Officer

321,962 0.3565%
2/23/26 Free

Chief Executive Officer

993,000 1.0994%
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%+1.37%-39.09%-29.52% 162M
+0.56%-4.71%-2.45%+9.18% 45.63B
+0.66%-2.34%+340.62%+530.14% 43.96B
+1.49%-0.78%+41.90%+24.75% 43.73B
+2.11%-1.24%+9.09%+78.25% 40.23B
+0.34%-4.03%+9.34%+38.90% 31.86B
+0.53%-2.08% - - 17.4B
+1.34%+0.70%+21.35%+112.62% 16.62B
+2.07%+0.78%+13.07%+30.91% 14.46B
-1.85%-5.33%+78.63%+31.45% 13.04B
Average +0.83%-1.42%+52.50%+91.85% 26.71B
Weighted average by Cap. +0.95%-2.01%+75.78%+127.84%

Financials

2026 *2027 *
Net sales 74.09M 64.2M 60.58M 54.96M 103M 7.1B 104M 724M 279M 3.6B 278M 272M 11.45B 88.44M 76.63M 72.32M 65.61M 123M 8.48B 124M 864M 333M 4.3B 332M 325M 13.67B
Net income -36.35M -31.5M -29.73M -26.97M -50.59M -3.48B -50.95M -355M -137M -1.77B -137M -134M -5.62B -28.54M -24.73M -23.34M -21.17M -39.72M -2.74B -40.01M -279M -107M -1.39B -107M -105M -4.41B
Net Debt - -
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
26-09-14 US$1.480 +1.02% 477,570
26-09-11 US$1.465 +1.74% 505,062
26-09-10 US$1.440 +0.70% 467,305
26-09-09 US$1.430 0.00% 513,300
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.480USD
Average target price
6.333USD
Spread / Average Target
+327.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CDXS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!